Suspected Denosumab-Associated Acute Coronary Syndrome
J Investig Med High Impact Case Rep. 2026 Jan-Dec;14:23247096261475824. doi: 10.1177/23247096261475824. Epub 2026 Aug 3.ABSTRACTDenosumab, a monoclonal antibody (mAb) targeting receptor activator of nuclear factor-κB ligand (RANKL), is commonly used in managing metabolic bone diseases and giant cell

